• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,958.52 940.73
( 1.22%)
Global Indices
Nasdaq
49,922.52 603.26
(1.22%)
Dow Jones
7,387.39 107.17
(1.47%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,442.09 222.98
(2.18%)
Forex
USD-INR
95.09 0.27
(0.28%)
EUR-INR
111.34 0.19
(0.17%)
GBP-INR
128.90 0.20
(0.16%)
JPY-INR
0.61 0.00
(0.29%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
17.34
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
299
68.4
EPS(TTM)
Face Value()
Div & Yield %
0.15
10
0
 

sru steels ltd
Mphasis consolidated net profit rises 14.14% in the March 2026 quarter
Apr 30,2026
Net profit of Mphasis rose 14.14% to Rs 509.64 crore in the quarter ended March 2026 as against Rs 446.49 crore during the previous quarter ended March 2025. Sales rose 14.36% to Rs 4242.67 crore in the quarter ended March 2026 as against Rs 3710.04 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.43% to Rs 1862.60 crore in the year ended March 2026 as against Rs 1702.14 crore during the previous year ended March 2025. Sales rose 11.59% to Rs 15879.65 crore in the year ended March 2026 as against Rs 14229.99 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4242.673710.04 14 15879.6514229.99 12
OPM %18.9418.94 -18.7518.60 -
PBDT834.11726.45 15 3100.022736.48 13
PBT681.32591.10 15 2544.752260.14 13
NP509.64446.49 14 1862.601702.14 9